a non-receptor tyrosine kinase of the Fer family. Appears to be involved in normal hematopoiesis as well as the development of acute promyelocytic leukemia. Contains one SH2 and one FCH domain. Four LOF point mutations seen in colorectal cancer. Orthologous to v-fes from feline leukemia virus and v-fps from avian transforming virus. Mutant forms are angiogenic. Promotes survival during differentiation, and may act both to promote and inhibit tumors. May be disrupted in the t(15q+;17q-) found in acute promyelocytic leukemia, but the breakpoint does not occur within the gene. Note: This description may include information from UniProtKB.
Protein type: EC 188.8.131.52; Protein kinase, tyrosine (non-receptor); Kinase, protein; Protein kinase, TK; TK group; Fer family
Cellular Component: microtubule cytoskeleton; Golgi apparatus; extrinsic to internal side of plasma membrane; focal adhesion; cytoplasmic membrane-bound vesicle; cytoplasm; cytoplasmic vesicle; cytosol
Molecular Function: protein binding; protein-tyrosine kinase activity; non-membrane spanning protein tyrosine kinase activity; ATP binding; phosphoinositide binding
Biological Process: regulation of cell adhesion; regulation of mast cell degranulation; regulation of cell shape; cell proliferation; axon guidance; peptidyl-tyrosine phosphorylation; positive regulation of myeloid cell differentiation; regulation of cell differentiation; positive regulation of microtubule polymerization; multicellular organismal development; protein amino acid autophosphorylation; protein amino acid phosphorylation; regulation of cell proliferation
SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.